CUA Educational Content

11th Annual Juravinski Cancer Centre and Walker Cancer Centre Uro-Oncology Forum (JCC) 2022

 

Bladder Cancer Session:

Multi-disciplinary Bladder Clinic: Gaps and Lessons Learned | WFCC: Michael Levesque / JCC: Himu Lukka
Regional Bladder Cancer Systemic Treatments Algorithm | Luisa Cardenas
CC Bladder Cancer Trials Update | Som Mukherjee

Kidney Cancer Session:

JCC Kidney Cancer Trials Update | Aly-Khan Lalani
Debate: Adjuvant Therapy in Kidney Cancer: Adjuvant IO should be available now (Sebastien Hotte) vs. Adjuvant IO should not be prescribed yet | 
Anil Kapoor

Prostate Cancer Session:

PARP inhibition in mCRPC | Aly-Khan Lalani
Genetic Testing and Mainstreaming Access: Regional Processes |Corissa Androich
mCSPC – Who should see the medical oncologist? | Sebastien Hotte
JCC Prostate Cancer Trials Update | Kimmen Quan
Hamilton PSMA PET Registry Update and Future Directions | Anil Kapoor 
Prostate Cancer Survivorship and CV Health, RADICAL PC Update | Jehonathan Pinthus

sponsors

The Canadian Urological Association (CUA) does not provide professional medical advice, diagnosis or treatment and cannot respond to requests for direct feedback, specific patient information or physician referrals. You should first always seek the advice of your urologist, physician and other qualified health provider with any questions regarding your medical condition. The contents of the CUA Website such as text, graphics, images, and other content are for informational purposes only. The content/information is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on the CUA website.

For comments or information, email Corporate.office@cua.org

Privacy Policy